1 report

HOWEVER, THE INCREASING POPULARITY OF DIGITAL HEALTHCARE SOLUTIONS AMONG DIFFERENT COMPANIES, AS WELL AS THE PATIENTS IS LIKELY TO ACCELERATE THE OVERALL ADOPTION OF THESE DEVICES IN THE NEAR FUTURE.

  • Genetic Disorder
  • North America
  • United States
  • AstraZeneca PLC
  • Novartis AG